Clinical trial of additional effects of lactic acid bacteria metabolites A6 for diabetes patients

Clinical trial of additional effects of lactic acid bacteria metabolites A6 for diabetes patients - Clinical trial of additional effects of lactic acid bacteria metabolites for diabetes patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049382

Enrollment

100

Registered

2022-10-31

Start date

1999-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

giving low doses of lactic acid bacteria metabolites giving high doses of lactic acid bacteria metabolites

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes patients whose diagnostic standard is a fasting blood glucose level of 120 mg/dl or higher, or a fasting blood glucose level of 180 mg/dl or higher 2 hours after a meal, according to WHO criteria

Exclusion criteria

Exclusion criteria: 1. Those with infectious diseases 2. Patients undergoing dialysis treatment

Design outcomes

Primary

Measure	Time frame
Biochemical index Patient's subjective symptoms and doctor's findings	—

Countries

Asia(except Japan)

Contacts

Public ContactAtsushi Kaneko

KOEI SCIENCE LABORATORY Co., Ltd. Sales Department

kaneko@koei-science.com048-467-3345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026